Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MYNZ Mainz Biomed B.V.

Trading 01-10 13:46:39 EST

4.48

+0.57

+14.45%

High4.84	Low3.86	Vol143.18K
Open4.11	D1 Closing3.91	Amplitude25.06%
Mkt Cap15.08M	Tradable Cap14.50M	Total Shares3.37M
T/O640.16K	T/O Rate4.42%	Tradable Shares3.24M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MYNZ","market":"US","secType":"STK","nameCN":"Mainz Biomed B.V.","latestPrice":4.475,"timestamp":1736534767653,"preClose":3.91,"halted":0,"volume":143177,"delay":0,"floatShares":3241311,"shares":3369000,"eps":-44.97834,"marketStatus":"Trading","change":0.565,"latestTime":"01-10 13:46:39 EST","open":4.11,"high":4.84,"low":3.86,"amount":640161.6055108,"amplitude":0.250639,"askPrice":4.6,"askSize":118,"bidPrice":4.22,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-44.97834,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1736542800000},"marketStatusCode":2,"adr":0,"listingDate":1635998400000,"exchange":"NASDAQ","adjPreClose":3.91,"preHourTrading":{"tag":"盘前","latestPrice":4.2,"preClose":3.91,"latestTime":"09:20 EST","volume":3468,"amount":15580.584762,"timestamp":1736518819233},"postHourTrading":{"tag":"盘后","latestPrice":4.28,"preClose":3.99,"latestTime":"19:49 EST","volume":1556,"amount":6866.066,"timestamp":1736383780666},"volumeRatio":3.480347},"requestUrl":"/m/hq/s/MYNZ/tweets","defaultTab":"tweets","newsList":[{"id":"2492176519","title":"Mainz Biomed Partners With Quest Diagnostics for Colorectal Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2492176519","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492176519?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:12","pubTimestamp":1734617557,"startTime":"0","endTime":"0","summary":"Mainz Biomed  said Thursday it partnered with Quest Diagnostics  to support the commercialization of its NextGen screening test for colorectal cancer.Under the agreement, the company said Quest will provide clinical trial laboratory services for its clinical trial involving about 15,000 participants across 150 US sites, adding that the study will generate data for FDA validation of the NextGen test.The medical test maker also said it would offer Quest semi-exclusive rights to provide testing services using the ColoAlert kit for 18 months, contingent on FDA approval.ColoAlert test is a stool-based test to detect colorectal cancer tumor DNA to help identify colorectal cancer in its early stages.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1854103824.USD","LU1854104046.USD","BK4583","BK4139","DGX","BK4567","BK4588","BK4196","BK4585","MYNZ"],"gpt_icon":0},{"id":"2492178610","title":"Mainz Biomed forms agreement with Quest Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2492178610","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492178610?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:27","pubTimestamp":1734614825,"startTime":"0","endTime":"0","summary":"Mainz Biomed (MYNZ) announced an agreement with Quest Diagnostics (DGX), a leading provider of diagnostic information services, to support commerci...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-forms-agreement-with-quest-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-forms-agreement-with-quest-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1854104046.USD","BK4196","BK4567","DGX","BK4585","MYNZ","BK4139","BK4588","BK4583","LU1854103824.USD"],"gpt_icon":0},{"id":"2492274521","title":"Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2492274521","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492274521?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:01","pubTimestamp":1734613260,"startTime":"0","endTime":"0","summary":"Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY, Calif. and MAINZ, Germany, Dec.  19, 2024  (GLOBE NEWSWIRE) -- Mainz Biom","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/19/2999823/0/en/Mainz-Biomed-Forms-Agreement-with-Quest-Diagnostics-to-Provide-Clinical-Trials-Laboratory-Services-for-Colorectal-Cancer-Screening-Test.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139","BK4213","BK4583","BK4196","CRC","BK4588","LU1854104046.USD","BK4567","BK4585","LU0266512127.USD","LU1854103824.USD","DGX","LU0456854461.SGD"],"gpt_icon":0},{"id":"2492462176","title":"Mainz Biomed Secures $8 Million in Follow-On Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2492462176","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492462176?lang=en_us&edition=fundamental","pubTime":"2024-12-17 06:47","pubTimestamp":1734389232,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. ( ($MYNZ) ) has provided an announcement. Mainz Biomed has successfully closed an $8 million follow-on offering, selling 1,367,52...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-secures-8-million-in-follow-on-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-secures-8-million-in-follow-on-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2492626816","title":"Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2492626816","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492626816?lang=en_us&edition=fundamental","pubTime":"2024-12-17 06:00","pubTimestamp":1734386400,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif. and MAINZ, Germany, Dec.  16, 2024  (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/16/2997929/0/en/Mainz-Biomed-Announces-Closing-of-8-0-Million-Follow-On-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2491369798","title":"Mainz Biomed NV trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2491369798","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491369798?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:45","pubTimestamp":1734360315,"startTime":"0","endTime":"0","summary":"09:43 EST Mainz Biomed (MYNZ) NV trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-nv-trading-resumes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-nv-trading-resumes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2491694773","title":"Mainz Biomed NV trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2491694773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491694773?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:35","pubTimestamp":1734359728,"startTime":"0","endTime":"0","summary":"09:33 EST Mainz Biomed (MYNZ) NV trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-mov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-nv-trading-halted-volatility-trading-pause?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-nv-trading-halted-volatility-trading-pause?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2491677523","title":"BRIEF-Mainz Biomed Announces Pricing Of $8.0 Million Follow-On Offering Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2491677523","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491677523?lang=en_us&edition=fundamental","pubTime":"2024-12-13 09:05","pubTimestamp":1734051925,"startTime":"0","endTime":"0","summary":"Dec 12 (Reuters) - Mainz Biomed NV   :   * MAINZ BIOMED ANNOUNCES PRICING OF $8.0 MILLION FOLLOW-ON OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES   * MAINZ BIOMED NV - EFFECTIVE OFFERING PRICE $5.85 PER UNITSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210149790.SGD","IE00BKPKM429.USD","QID","LU2095319765.USD","NVIW.SI","PSQ","LU2210150020.SGD","NQmain","TQQQ","QLD",".IXIC","BK4588","NDAQ","TSYW.SI","BK4112","IE00B64PRP62.GBP","MNQmain","MYNZ","SQQQ","BK4139","BK4585","USAW.SI","USJW.SI","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2491367736","title":"Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2491367736","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491367736?lang=en_us&edition=fundamental","pubTime":"2024-12-13 09:00","pubTimestamp":1734051600,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif. and MAINZ, Germany, Dec.  12, 2024  (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/13/2996589/0/en/Mainz-Biomed-Announces-Pricing-of-8-0-Million-Follow-On-Offering-Priced-at-the-Market-Under-Nasdaq-Rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","QID","BK4112","USJW.SI","MYNZ","IE00B3QW5Z07.USD","LU2210149790.SGD","SQQQ","NDAQ","IE00BGHQF748.EUR","BK4588","TSYW.SI","LU2095319765.USD","TQQQ","NQmain","NVIW.SI","IE00B64PRP62.GBP","QLD","IE00BKPKM429.USD",".IXIC","MNQmain","PSQ","LU2210150020.SGD","USAW.SI","BK4139"],"gpt_icon":1},{"id":"2487986557","title":"Mainz Biomed to Implement 1-for-40 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2487986557","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487986557?lang=en_us&edition=fundamental","pubTime":"2024-11-29 22:21","pubTimestamp":1732890117,"startTime":"0","endTime":"0","summary":"Mainz Biomed  said Friday it is implementing a one-for-40 reverse stock split of its common stock, effective Dec. 3, following the board's decision on Nov. 20.No fractional shares will be issued. Instead, Mainz Biomed will pay cash depending on the value of the fractional shares, the company said.The company's shares were down more than 12% in recent premarket trading.Price: 0.22, Change: -0.032, Percent Change: -12.50","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2487557669","title":"Mainz Biomed Initiates Reverse Stock Split Amid Nasdaq Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=2487557669","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487557669?lang=en_us&edition=fundamental","pubTime":"2024-11-29 22:17","pubTimestamp":1732889844,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed announced a 1-for-40 reverse stock split to maintain its Nasdaq listing, aiming to bo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-initiates-reverse-stock-split-amid-nasdaq-challenge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-initiates-reverse-stock-split-amid-nasdaq-challenge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKPKM429.USD","TQQQ","BK4139","IE00BGHQF748.EUR",".IXIC","IE00B3QW5Z07.USD","NQmain","PSQ","BK4112","IE00B64PRP62.GBP","MYNZ","LU2210149790.SGD","NDAQ","BK4585","LU2095319765.USD","QID","QLD","MNQmain","SQQQ","LU2210150020.SGD","BK4588"],"gpt_icon":0},{"id":"2487560552","title":"Mainz Biomed announces 1-for-40 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2487560552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487560552?lang=en_us&edition=fundamental","pubTime":"2024-11-29 21:50","pubTimestamp":1732888217,"startTime":"0","endTime":"0","summary":"Mainz Biomed (MYNZ) announced a 1-for-40 reverse stock split of its issued and outstanding shares. The reverse stock split was authorized by the Bo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-announces-1-for-40-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-announces-1-for-40-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2487554108","title":"Mainz Biomed Announces Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2487554108","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487554108?lang=en_us&edition=fundamental","pubTime":"2024-11-29 21:45","pubTimestamp":1732887900,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2024  -- Mainz Biomed N.V.  , a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a 1-for-40 reverse stock split of its issued and outstanding shares. The reverse stock split was authorized by the Board of Directors of the Company pursuant to shareholder approval granted at its Extraordinary Shareholders Meeting on November 20, 2024.The reverse stock split is expected to become effective on December 3, 2024 , and the Company’s ordinary shares are expected to begin trading on the split-adjusted basis on the Nasdaq under the Company's existing trading symbol \"MYNZ\" at market open on December 3, 2024, upon Nasdaq's approval. The new CUSIP number for the Company's ordinary shares following the reverse stock split will be N5436L119.The reverse stock split is intended to increase the market price per share of its common stock to comply with the continued listing standards of the Nasdaq Capital Ma","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4gdf1aP2KF31Of5j_v4jzA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fa079afc58b5fef8ae5aa677600f9292","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4gdf1aP2KF31Of5j_v4jzA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fa079afc58b5fef8ae5aa677600f9292"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mainz-biomed-announces-stock-split-134500760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","LU2041044095.USD","A","QID","PSQ","NQmain","TQQQ","LU2413666699.HKD","QLD",".IXIC","LU1721428933.USD","LU1543694498.USD","BK4588","LU1165135440.EUR","MNQmain","MYNZ","LU0347712357.USD","SQQQ","LU2413666426.HKD","BK4139","BK4585","BK4567","LU2092937221.SGD"],"gpt_icon":1},{"id":"2486085678","title":"HC Wainwright Downgrades Mainz Biomed N.V to Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2486085678","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486085678?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:39","pubTimestamp":1732538372,"startTime":"0","endTime":"0","summary":"HC Wainwright Downgrades Mainz Biomed N.V to Neutral","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYNZ"],"gpt_icon":0},{"id":"2486252088","title":"Mainz Biomed Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2486252088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486252088?lang=en_us&edition=fundamental","pubTime":"2024-11-25 20:09","pubTimestamp":1732536540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MYNZ/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2024 07:09 ET (12:09 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ"],"gpt_icon":0},{"id":"2486700063","title":"Mainz Biomed Nv : H.c. Wainwright Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2486700063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486700063?lang=en_us&edition=fundamental","pubTime":"2024-11-25 19:57","pubTimestamp":1732535849,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nFWN3MW0LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2483312615","title":"Mainz Biomed Considers Reverse Stock Split for Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2483312615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483312615?lang=en_us&edition=fundamental","pubTime":"2024-11-16 06:40","pubTimestamp":1731710423,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed N.V. held an extraordinary general meeting where key proposals, including a reverse s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-considers-reverse-stock-split-for-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-considers-reverse-stock-split-for-nasdaq-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU2095319765.USD","IE00BKPKM429.USD","LU2210149790.SGD","TQQQ","BK4139","QID","SQQQ","LU2210150020.SGD","IE00BGHQF748.EUR","NDAQ","QLD","NQmain","MYNZ","BK4112","MNQmain","IE00B64PRP62.GBP","BK4585","IE00B3QW5Z07.USD","PSQ",".IXIC"],"gpt_icon":0},{"id":"2483629278","title":"The Oncology Bet Is Already Paying Off For Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2483629278","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483629278?lang=en_us&edition=fundamental","pubTime":"2024-11-14 08:23","pubTimestamp":1731543795,"startTime":"0","endTime":"0","summary":"With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc  reported its third quarter revenue grew14% on an operational basisdue to approved cancer products from Seagen it acquired last December. On the other hand, Moderna Inc  posted a surprise profit and higher than expected revenue following the launch of its updated Covid-19 vaccine earlier this year as focused on slashing costs. But, even with Covid-19 still lingering in the air, Moderna has also focused on harnessing the power of mRNA to make biotech history by revolutionizing cancer treatment. However, there is also a significant advancement in early screening and even possible prevention when it comes to the cancer front. For example, their much smaller peer,Mainz Biomed  just announced a new collaboration agreement aimed at developing and potentially commercializing its next generation colorectal cancer screening product.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/T17My1Xowf0ctud5YtvJcg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/eeac3cc78e2352f7fe351184c2b1bf99","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/T17My1Xowf0ctud5YtvJcg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/eeac3cc78e2352f7fe351184c2b1bf99"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncology-bet-already-paying-off-002315025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z3B42.SGD","BK4139","BK4550","IE00BJJMRZ35.SGD","LU1883839398.USD","BK4534","LU0170899867.USD","LU1923622614.USD","LU0225284248.USD","GB00BDT5M118.USD","LU1923622291.USD","LU0122379950.USD","LU1894683348.USD","MYNZ","LU2089984988.USD","BK4568","LU1023059063.AUD","MRNA","PFE","LU1291159041.SGD","IE0002270589.USD","LU0321505868.SGD","LU0528227936.USD","BK4585","LU2092937221.SGD","BK4551","SG9999011175.SGD","TMO","BK4533","IE0034235188.USD","BK4535","IE000M9KFDE8.USD","LU1623119135.USD","LU1280957306.USD","LU0868494617.USD","LU1712237335.SGD","LU1791710400.SGD","LU0557290698.USD","IE0002141913.USD","LU0061474960.USD","LU1791710582.SGD","BK4581","BK4566","SG9999001176.USD","IE00BLSP4452.SGD","LU0342679015.USD","LU0114720955.EUR","LU1720051108.HKD"],"gpt_icon":1},{"id":"2482082994","title":"Mainz Biomed Partners with Thermo Fisher for Cancer Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2482082994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482082994?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:39","pubTimestamp":1731425964,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed has announced a collaboration with Thermo Fisher Scientific to develop a next-generat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-partners-with-thermo-fisher-for-cancer-screening?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-partners-with-thermo-fisher-for-cancer-screening?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2482008676","title":"Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2482008676","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482008676?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:54","pubTimestamp":1731423296,"startTime":"0","endTime":"0","summary":"Mainz Biomed N.V  said Tuesday it has partnered with Thermo Fisher Scientific  to develop a colorectal cancer screening test.Financial details of the partnership were not disclosed.Mainz said the partnership will combine its experience in mRNA-based colorectal cancer detection with Thermo Fisher's technology resources to develop a non-invasive test for detecting early-stage colorectal cancer and precancerous growths.Shares of Mainz Biomed rose nearly 7% in recent Tuesday trading, while Thermo Fisher's rose 0.3%.Price: 0.23, Change: +0.01, Percent Change: +6.51","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0316494557.USD","IE00BJT1NW94.SGD","LU1280957306.USD","BK4139","IE0002141913.USD","LU1923622291.USD","LU0011850046.USD","GB00BDT5M118.USD","IE00B19Z8W00.USD","LU1064131342.USD","LU1815333072.USD","BK4535","LU1854103824.USD","BK4581","TMO","LU1791710582.SGD","LU0528227936.USD","LU1057294990.SGD","LU1670627923.USD","BK4548","LU0061474960.USD","LU0882574055.USD","LU0957791311.USD","IE00B2B36J28.USD","LU1791710400.SGD","LU2092937221.SGD","LU0096362180.USD","LU0557290698.USD","MYNZ","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1670628061.USD","BK4534","IE00B1BXHZ80.USD","LU1720051017.SGD","LU0342679015.USD","BK4566","LU0640476718.USD","LU1633808545.USD","LU1989771016.USD","LU1923621640.USD","LU0266013472.USD","LU1854104046.USD","LU1988902786.USD","LU2089984988.USD","LU1720051108.HKD","BK4533","LU0823416689.USD","LU1548497426.USD","LU2041044095.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://mainzbiomed.com","stockEarnings":[{"period":"1week","weight":-0.0764},{"period":"1month","weight":-0.4},{"period":"3month","weight":-0.6919},{"period":"6month","weight":-0.7912},{"period":"1year","weight":-0.9093},{"period":"ytd","weight":-0.0764}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.0232},{"period":"6month","weight":0.0527},{"period":"1year","weight":0.244},{"period":"ytd","weight":0.0058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.050597},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.035908},{"month":3,"riseRate":0.666667,"avgChangeRate":0.025772},{"month":4,"riseRate":0,"avgChangeRate":-0.221085},{"month":5,"riseRate":0.333333,"avgChangeRate":0.100259},{"month":6,"riseRate":0,"avgChangeRate":-0.2895},{"month":7,"riseRate":0.666667,"avgChangeRate":0.026169},{"month":8,"riseRate":0,"avgChangeRate":-0.198742},{"month":9,"riseRate":0,"avgChangeRate":-0.185486},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.099325},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.099795},{"month":12,"riseRate":0.5,"avgChangeRate":-0.153854}],"exchange":"NASDAQ","name":"Mainz Biomed B.V.","nameEN":"Mainz Biomed B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mainz Biomed B.V.(MYNZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mainz Biomed B.V.,MYNZ,Mainz Biomed B.V.股票,Mainz Biomed B.V.股票老虎,Mainz Biomed B.V.股票老虎国际,Mainz Biomed B.V.行情,Mainz Biomed B.V.股票行情,Mainz Biomed B.V.股价,Mainz Biomed B.V.股市,Mainz Biomed B.V.股票价格,Mainz Biomed B.V.股票交易,Mainz Biomed B.V.股票购买,Mainz Biomed B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mainz Biomed B.V.(MYNZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction